BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 29240024)

  • 1. Preventing and Managing Toxicities of High-Dose Methotrexate.
    Howard SC; McCormick J; Pui CH; Buddington RK; Harvey RD
    Oncologist; 2016 Dec; 21(12):1471-1482. PubMed ID: 27496039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carboxypeptidase G2 rescue in patients with methotrexate intoxication and renal failure.
    Buchen S; Ngampolo D; Melton RG; Hasan C; Zoubek A; Henze G; Bode U; Fleischhack G
    Br J Cancer; 2005 Feb; 92(3):480-7. PubMed ID: 15668713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case files of the New York City Poison Control Center: antidotal strategies for the management of methotrexate toxicity.
    Smith SW; Nelson LS
    J Med Toxicol; 2008 Jun; 4(2):132-40. PubMed ID: 18570175
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase 2 study of glucarpidase in patients with delayed methotrexate elimination after high-dose methotrexate therapy.
    Ogawa A; Kawamoto H; Hara J; Kikuta A; Ogawa C; Hiraga H; Yoshimura K; Miyairi K; Omori R; Ro T; Kamei Y; Kimura T
    Cancer Chemother Pharmacol; 2024 Mar; ():. PubMed ID: 38478074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early intervention is important when administering glucarpidase for methotrexate intoxication. Author's reply.
    Miceli G; Daidone M; Corpora F; Di Gaudio F; Tuttolomondo A;
    Eur J Intern Med; 2024 Apr; ():. PubMed ID: 38685140
    [No Abstract]   [Full Text] [Related]  

  • 6. Rare incidence of tumor lysis syndrome in metastatic prostate cancer following treatment with docetaxel.
    Bhardwaj S; Varma S
    J Oncol Pharm Pract; 2018 Mar; 24(2):153-155. PubMed ID: 29284359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful conservative treatment of enterocutaneous fistula with cyanoacrylate surgical sealant: case report.
    Musa N; Aquilino F; Panzera P; Martines G
    G Chir; 2017; 38(5):256-259. PubMed ID: 29280707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Patients with Acute Methotrexate Nephrotoxicity with High-Dose Leucovorin.
    Flombaum CD; Liu D; Yan SQ; Chan A; Mathew S; Meyers PA; Glezerman IG; Muthukumar T
    Pharmacotherapy; 2018 Jul; 38(7):714-724. PubMed ID: 29863765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life-threatening complications after high-dose methotrexate and the benefits of glucarpidase as salvage therapy: a cohort study of 468 patients.
    Medrano C; Oberic L; Puisset F; Recher C; Larrieu-Ciron D; Ysebaert L; Protin C; Picard M; Perriat S; Chatelut E; Bertoli S; Huguet F; Tavitian S; Faguer S
    Leuk Lymphoma; 2021 Apr; 62(4):846-853. PubMed ID: 33179543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Massively parallel, computationally guided design of a proenzyme.
    Yachnin BJ; Azouz LR; White RE; Minetti CASA; Remeta DP; Tan VM; Drake JM; Khare SD
    Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2116097119. PubMed ID: 35377786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Length of stay, mortality, and readmissions among Medicare cancer patients treated with glucarpidase and conventional care: a retrospective study.
    Demiralp B; Koenig L; Kala J; Feng C; Hamlett EG; Steele-Adjognon M; Ward S
    Clinicoecon Outcomes Res; 2019; 11():129-144. PubMed ID: 30799942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed Methotrexate Clearance Despite Carboxypeptidase-G2 (Glucarpidase) Administration in 2 Patients With Toxic Methotrexate Levels.
    Wyatt KD; Cooper J; Scott K; Broomall E; Altaf S; Hogan MC; Rodriguez V; Khan S
    J Pediatr Hematol Oncol; 2018 Mar; 40(2):152-155. PubMed ID: 29240024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucarpidase rescue in a patient with high-dose methotrexate-induced nephrotoxicity.
    Tuffaha HW; Al Omar S
    J Oncol Pharm Pract; 2011 Jun; 17(2):136-40. PubMed ID: 19833686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of glucarpidase (carboxypeptidase g2) in patients with acute kidney injury after high-dose methotrexate therapy.
    Widemann BC; Schwartz S; Jayaprakash N; Christensen R; Pui CH; Chauhan N; Daugherty C; King TR; Rush JE; Howard SC
    Pharmacotherapy; 2014 May; 34(5):427-39. PubMed ID: 24132809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance.
    Ramsey LB; Balis FM; O'Brien MM; Schmiegelow K; Pauley JL; Bleyer A; Widemann BC; Askenazi D; Bergeron S; Shirali A; Schwartz S; Vinks AA; Heldrup J
    Oncologist; 2018 Jan; 23(1):52-61. PubMed ID: 29079637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucarpidase treatment for methotrexate intoxication: a case report and review of the literature.
    Boelens AD; Mathôt RAA; Vlaar APJ; Bouman CSC
    Neth J Med; 2018 Jan; 76(1):36-39. PubMed ID: 29380731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucarpidase following high-dose methotrexate: update on development.
    Patterson DM; Lee SM
    Expert Opin Biol Ther; 2010 Jan; 10(1):105-11. PubMed ID: 19925307
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.